Company registration number 05138580 (England and Wales)
RAMOS HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
RAMOS HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
Mr L Ramos
Mrs A Tan-Ramos
Secretary
Mr J P Ramos
Company number
05138580
Registered office
34 Scarisbrick New Road
Southport
PR8 6QE
Auditor
MHA
Richard House
9 Winckley Square
Preston
PR1 3HP
RAMOS HEALTHCARE LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 17
RAMOS HEALTHCARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 JULY 2024
- 1 -
The directors present the strategic report for the year ended 31 July 2024.
Review of the business
Following the group restructure in a prior year, the company is now dormant except for a small number of residual transactions arising after the hive down of trade and assets to its wholly-owned subsidiary.
The company remains the parent company of Laburnum House (Shaw) Limited. A strategic report covering the business of Laburnum House (Shaw) Limited can be found in that company's financial statements.
Mr L Ramos
Director
25 April 2025
RAMOS HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JULY 2024
- 2 -
The directors present their annual report and financial statements for the year ended 31 July 2024.
Principal activities
The principal activity of the company continued to be that of a holding company.
Results and dividends
The results for the year are set out on page 7.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr L Ramos
Mrs A Tan-Ramos
Auditor
The auditor, MHA, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
Mr L Ramos
Director
25 April 2025
RAMOS HEALTHCARE LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 JULY 2024
- 3 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
RAMOS HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RAMOS HEALTHCARE LIMITED
- 4 -
Opinion
We have audited the financial statements of Ramos Healthcare Limited (the 'company') for the year ended 31 July 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 July 2024 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
RAMOS HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RAMOS HEALTHCARE LIMITED (CONTINUED)
- 5 -
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud, is detailed below:
Enquiries with management about any known or suspected instances of non-compliance with laws and regulations;
Enquires with management about any known or suspected instances of fraud;
Assessing management's significant judgements and estimate;
Examination of journal entries and other adjustments to test for appropriateness and identify any instances of management override of controls.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
RAMOS HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RAMOS HEALTHCARE LIMITED (CONTINUED)
- 6 -
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Paul Williams BA(Hons) FCA
Senior Statutory Auditor
For and on behalf of MHA, Statutory Auditor
Preston, United Kingdom
25 April 2025
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542)
RAMOS HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JULY 2024
- 7 -
2024
2023
Notes
£
£
Turnover
3
-
-
Administrative expenses
(9,289)
(5,590)
Other operating income
293
Operating loss
4
(9,289)
(5,297)
Interest receivable and similar income
6
224,880
Interest payable and similar expenses
7
(37)
(16)
(Loss)/profit before taxation
(9,326)
219,567
Tax on (loss)/profit
8
(Loss)/profit for the financial year
(9,326)
219,567
The profit and loss account has been prepared on the basis that all operations are continuing operations.
RAMOS HEALTHCARE LIMITED
BALANCE SHEET
- 8 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investments
10
1,605,880
1,605,880
Current assets
Debtors
12
298,418
207,723
Cash at bank and in hand
2,814
653
301,232
208,376
Creditors: amounts falling due within one year
13
(565,163)
(462,981)
Net current liabilities
(263,931)
(254,605)
Net assets
1,341,949
1,351,275
Capital and reserves
Called up share capital
14
60
60
Profit and loss reserves
15
1,341,889
1,351,215
Total equity
1,341,949
1,351,275
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 25 April 2025 and are signed on its behalf by:
Mr L Ramos
Director
Company registration number 05138580 (England and Wales)
RAMOS HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JULY 2024
- 9 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 August 2022
60
1,350,528
1,350,588
Year ended 31 July 2023:
Profit and total comprehensive income
-
219,567
219,567
Dividends
9
-
(218,880)
(218,880)
Balance at 31 July 2023
60
1,351,215
1,351,275
Year ended 31 July 2024:
Loss and total comprehensive income
-
(9,326)
(9,326)
Balance at 31 July 2024
60
1,341,889
1,341,949
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
- 10 -
1
Accounting policies
Company information
Ramos Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 34 Scarisbrick New Road, Southport, PR8 6QE.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold . The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income.
The company has taken advantage of the exemption under section 400(1)(c) of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.
Ramos Healthcare Limited is a wholly owned subsidiary of Bloomcare Group Limited and the results of Ramos Healthcare Limited are included in the consolidated financial statements of Bloomcare Group Limited which are available from Companies House, Cardiff or from its registered office.
1.2
Going concern
The company is now a holding company with minimal activity. Therefore, atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
1
Accounting policies
(Continued)
- 11 -
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
1.4
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.5
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
All of the company's financial assets are classed as basic financial assets.
Impairment of financial assets
Financial assets are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
1
Accounting policies
(Continued)
- 12 -
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
All of the company's financial liabilities are classed as basic financial liabilities.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.6
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.7
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.8
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
- 13 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
Impairment of the investment in subsidiary
Each financial year the directors undertake an assessment of the net book value of the investment in the subsidiary and whether there are any indicators of impairment. There have been no indicators of impairment identified during the current financial year.
3
Revenue
2024
2023
£
£
Dividends received
-
224,880
4
Operating loss
2024
2023
Operating loss for the year is stated after charging:
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
1,152
1,080
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Management and head office
3
3
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
5
Employees
(Continued)
- 14 -
Their aggregate remuneration comprised:
2024
2023
£
£
Wages and salaries
173
Social security costs
3,272
3,197
3,445
3,197
6
Interest receivable and similar income
2024
2023
£
£
Income from fixed asset investments
Income from shares in group undertakings
224,880
7
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
37
16
8
Taxation
The actual charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
(Loss)/profit before taxation
(9,326)
219,567
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 21.01%)
(2,332)
46,131
Tax effect of expenses that are not deductible in determining taxable profit
12
Tax effect of income not taxable in determining taxable profit
(47,237)
Group relief
2,332
1,104
Other non-reversing timing differences
(10)
Taxation charge for the year
-
-
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
- 15 -
9
Dividends
2024
2023
£
£
Final paid
218,880
10
Fixed asset investments
2024
2023
Notes
£
£
Investments in subsidiaries
11
1,605,880
1,605,880
11
Subsidiaries
Details of the company's subsidiaries at 31 July 2024 are as follows:
Name of undertaking
Address
Nature of business
Class of
% Held
shares held
Direct
Laburnum House (Shaw) Limited
1
The operation of a residential care home
Ordinary
100.00
Registered office addresses (all UK unless otherwise indicated):
1
34 Scarisbrick New Road, Southport, Merseyside, PR8 6QE
12
Debtors
2024
2023
Amounts falling due within one year:
£
£
Corporation tax recoverable
58,531
39,872
Amounts owed by group undertakings
64,187
47,436
Other debtors
175,700
120,415
298,418
207,723
13
Creditors: amounts falling due within one year
2024
2023
£
£
Amounts owed to group undertakings
524,204
437,601
Corporation tax
38,552
19,893
Other creditors
3,207
Accruals and deferred income
2,407
2,280
565,163
462,981
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
- 16 -
14
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
60
60
60
60
15
Profit and loss reserves
Included within profit and loss reserves are non-distributable reserves of £1,217,319 (2023: £1,217,319) relating to revalued properties which have been transferred out of the company but are still held within the group.
16
Financial commitments, guarantees and contingent liabilities
The company has provided a debenture to a lender in the parent company which at 31 July 2024 amounted to £7,974,988.
17
Operating lease commitments
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2024
2023
£
£
Within one year
1,185
18
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
Category
Description of
Income
Expenditure
transaction
2024
2023
2024
2023
£
£
£
£
Entities with control, joint control or significant influence over the company
2,400
Balances with related parties
At the year end the following balances were owed by/(from) related parties.
RAMOS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
18
Related party transactions
(Continued)
- 17 -
Category
Amounts owed by
Amounts owed to
related parties
related parties
2024
2023
2024
2023
£
£
£
£
Entities with control, joint control or significant influence over the company
64,187
47,463
Other related parties
175,700
120,415
14,300
10,200
Other information
Details of guarantees provided in respect of related parties can be found in note 16.
The company has taken advantage of the exemption permitted under Section 33.1A from disclosing transactions with the subsidiary company.
19
Directors' transactions
Dividends totalling £0 (2023 - £0) were paid in the year in respect of shares held by the company's directors.
Description
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
Director's loan
-
80,385
20,000
100,385
80,385
20,000
100,385
Loans made to the directors are interest free and repayable on demand.
20
Ultimate controlling party
The ultimate controlling party is Bloomcare Group Limited, a company registered in England and Wales. The registered office is 34 Scarisbrick New Road, Southport, United Kingdom, PR8 6QE.
The consolidated financial statements of the group are available to the public and may be obtained from Companies House, Cardiff or from its registered office.
The following are the parents of the largest and smallest groups in which this company's results are consolidated:
Largest group
Bloomcare Group Limited
Smallest group
Bloomcare Group Limited
2024-07-312023-08-01falsefalsefalseCCH SoftwareCCH Accounts Production 2024.301Mr L RamosMrs A Tan-RamosMr J P Ramos051385802023-08-012024-07-3105138580bus:Director12023-08-012024-07-3105138580bus:Director22023-08-012024-07-3105138580bus:CompanySecretary12023-08-012024-07-3105138580bus:RegisteredOffice2023-08-012024-07-31051385802024-07-31051385802022-08-012023-07-3105138580core:RetainedEarningsAccumulatedLosses2022-08-012023-07-3105138580core:RetainedEarningsAccumulatedLosses2023-08-012024-07-31051385802023-07-3105138580core:CurrentFinancialInstrumentscore:WithinOneYear2024-07-3105138580core:CurrentFinancialInstrumentscore:WithinOneYear2023-07-3105138580core:CurrentFinancialInstruments2024-07-3105138580core:CurrentFinancialInstruments2023-07-3105138580core:ShareCapital2024-07-3105138580core:ShareCapital2023-07-3105138580core:RetainedEarningsAccumulatedLosses2024-07-3105138580core:RetainedEarningsAccumulatedLosses2023-07-3105138580core:ShareCapital2022-07-3105138580core:RetainedEarningsAccumulatedLosses2022-07-3105138580core:UKTax2023-08-012024-07-3105138580core:UKTax2022-08-012023-07-3105138580core:Non-currentFinancialInstruments2024-07-3105138580core:Non-currentFinancialInstruments2023-07-3105138580core:Subsidiary112023-08-012024-07-310513858012023-08-012024-07-3105138580core:WithinOneYear2024-07-3105138580core:WithinOneYear2023-07-3105138580core:ManagementRechargesServices2023-08-012024-07-3105138580core:ManagementRechargesServices2022-08-012023-07-3105138580core:OtherGroupMember12024-07-3105138580core:OtherGroupMember12023-07-3105138580core:OtherGroupMember22024-07-3105138580core:OtherGroupMember22023-07-3105138580core:OtherGroupMember1core:OtherTransactionType12024-07-3105138580core:OtherGroupMember2core:OtherTransactionType22023-07-3105138580bus:PrivateLimitedCompanyLtd2023-08-012024-07-3105138580bus:FRS1022023-08-012024-07-3105138580bus:Audited2023-08-012024-07-3105138580bus:FullAccounts2023-08-012024-07-31xbrli:purexbrli:sharesiso4217:GBP